Back |
home / stock / snpx / snpx message board
Subject | By | Source | When |
---|---|---|---|
Snake oil and another attempt to spin a | urge2surge | investorshub | 03/07/2023 3:48:53 PM |
Nice update! | Battle Ready | investorshub | 03/07/2023 3:25:09 PM |
Synaptogenix Provides Corporate Update and Outlines Potential Business Oppor | Cyosol | investorshub | 03/07/2023 2:04:40 PM |
Thank you. Yes, a good technical presentation that | Babaji | investorshub | 02/28/2023 11:54:32 PM |
re. Thoughts? | FooBarAndGrill | investorshub | 02/28/2023 3:06:52 PM |
Thanks. Seems like an alternative to imaging, highly | Babaji | investorshub | 02/28/2023 2:18:02 PM |
At Mayo, the test may have been this: | FooBarAndGrill | investorshub | 02/27/2023 1:05:11 PM |
Thanks Coach. | Babaji | investorshub | 02/20/2023 4:44:16 AM |
Thank you. Will pass on. | Babaji | investorshub | 02/20/2023 4:43:58 AM |
There are 2 different CSF tests, both with | Doc328 | investorshub | 02/18/2023 9:19:58 PM |
I typically use Pure Encapsulation's products but I | runncoach | investorshub | 02/18/2023 7:32:29 PM |
RC and Battle: Looks like there are many Lions | Babaji | investorshub | 02/18/2023 2:36:24 PM |
znewcar1: SNPX 29% v4,0M c10.09 f6,67M H10.65 morning pop S@7.2 | znewcar1 | investorshangout | 02/01/2022 10:57:44 PM |
znewcar1: Interesting chart showing S@8 w/a bullish signal >9 anything over 14 is free for all. What | znewcar1 | investorshangout | 01/10/2022 4:17:32 AM |
News, Short Squeeze, Breakout and More Instantly...
Synaptogenix Inc. Company Name:
SNPX Stock Symbol:
OTCMKTS Market:
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis PR Newswire Collaborative study will evaluate drug's potential to improve synaptic health and cognitive function in MS patients NEW YORK , ...
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery PR Newswire Proposed Schedule III drug classification expected to de-risk Cannasoul's cannabis research and potential regulatory pathways ...